Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells

Authors
Kim, EunheeKim, MisukWoo, Dong-HunShin, YongjaeShin, JihyeChang, NakhoOh, Young TaekKim, HongRheey, JingeunNakano, IchiroLee, CheoljuJoo, Kyeung MinRich, Jeremy N.Nam, Do-HyunLee, Jeongwu
Issue Date
2013-06-10
Publisher
CELL PRESS
Citation
CANCER CELL, v.23, no.6, pp.839 - 852
Abstract
Glioblastoma multiforme (GBM) displays cellular hierarchies harboring a subpopulation of stem-like cells (GSCs). Enhancer of Zeste Homo log 2 (EZH2), the lysine methyltransferase of Polycomb repressive complex 2, mediates transcriptional repression of prodifferentiation genes in both normal and neoplastic stem cells. An oncogenic role of EZH2 as a transcriptional silencer is well established; however, additional functions of EZH2 are incompletely understood. Here, we show that EZH2 binds to and methylates STAT3, leading to enhanced STAT3 activity by increased tyrosine phosphorylation of STAT3. The EZH2-STAT3 interaction preferentially occurs in GSCs relative to non-stem bulk tumor cells, and it requires a specific phosphorylation of EZH2. Inhibition of EZH2 reverses the silencing of Polycomb target genes and diminishes STAT3 activity, suggesting therapeutic strategies.
Keywords
TUMOR-INITIATING CELLS; GROUP PROTEIN EZH2; NF-KAPPA-B; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; MEDIATED REPRESSION; GENE-EXPRESSION; POLYCOMB; CANCER; INHIBITOR; TUMOR-INITIATING CELLS; GROUP PROTEIN EZH2; NF-KAPPA-B; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; MEDIATED REPRESSION; GENE-EXPRESSION; POLYCOMB; CANCER; INHIBITOR
ISSN
1535-6108
URI
https://pubs.kist.re.kr/handle/201004/127968
DOI
10.1016/j.ccr.2013.04.008
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE